UC Riverside professor organizes a workshop on vitamin D and cancer treatment and prevention

UC Riverside Professor Anthony Norman, regarded as one of the world's leading experts on Vitamin D, is organizing a three-day meeting on Vitamin D and cancer treatment and prevention on Wednesday, November 17 through Friday, November 19, 2004, in Bethesda, Md.

The Vitamin D Workshop, founded 30 years ago, is partnering with the National Cancer Institute to co-sponsor the event, which will be held at the National Institutes of Health (NIH) campus.

The purpose of this meeting is to bring together two groups of scientists, those who research cancer prevention and treatments with scientists who research Vitamin D, or more specifically, the steroid hormone form of vitamin D, 1,25-dihydroxy-vitamin D, also known as Hormone D. In 1967, Norman's laboratory at UC Riverside discovered that vitamin D is converted into this steroid hormone by the body.

Many laboratories are working on drug forms of Hormone D for treatment of some cancers, particularly prostate cancer and leukemia, Norman said. "There is also much interest in what is the proper amount of the parent vitamin D - not the hormone - that an average individual should receive each day."

Norman's laboratory is currently involved in better understanding the molecular mechanisms of how Hormone D generates biological responses.

A distinguished professor of biochemistry and biomedical sciences at UCR, Prof. Norman has served as one of three principal organizers of the Vitamin D Workshop, which has held an international meeting every three years, alternating between Europe and the USA. The Workshop celebrated its 30th anniversary in 2003 at the 12th Vitamin D Workshop in Maastricht, The Netherlands. The next Vitamin D Workshop will be held April 7-12, 2006 in Victoria, B.C., Canada.


Contact: Kris Lovekin
University of California - Riverside

Page: 1

Related biology news :

1. UC Riverside researchers show how the brain turns on innate behavior
2. UC Riverside researchers release new variety of asparagus
3. UC Riverside researchers identify clay as major contributor to oxygen that enabled early animal life
4. UC Riverside researchers discover model organism for studying viruses that affect humans
5. A $2 Million NSF grant brings technology and biology together at UC Riverside
6. National Science Foundation awards $2 million grant to UC Riverside
7. Decorated UH professor to help choose nations top scientists
8. UCF professor finds bacterial pathogen may be key to understanding cancer development
9. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
10. 2 MSU professors spearhead international water project
11. WPI professor to represent American Mathematical Society at exhibition on science funding

Post Your Comments:

(Date:5/31/2019)... ... May 30, 2019 , ... Enso Discoveries Chief Executive Officer, Patrick Farley, is ... as a way to express his gratitude and respect for those who have served ... Enso Discoveries — presented a check for $1,000 to the Green Beret ...
(Date:5/24/2019)... (PRWEB) , ... May 24, 2019 , ... The newest ... and is now available on the company’s global website. , Crystallography Times is a ... crystal X-ray diffraction. It serves the X-ray analysis community by presenting the latest news ...
(Date:5/23/2019)... SAN FRANCISCO (PRWEB) , ... May 23, 2019 ... ... Intelligent Virtual Agents for sales and service organizations, today announced its ... report identifies Inference Solutions as the intelligent virtual agent (IVA) market share leader, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
Breaking Biology Technology:
Cached News: